002688.SZ
金河生物
SZSE · Healthcare · C 制造业 · CN
CNY 5.18
+0.19%Aug 27, 2026, 10:21 UTC
Jinhe Biotechnology announced its first-half 2026 results: revenue of 1.448 billion yuan, up 4.13% year-on-year; net profit attributable to shareholders of 131 million yuan, down 5.09% year-on-year.
Jul 31, 2026, 07:44 UTC
Jinhe Biological's subsidiary Jinhe Youben Biological Products Co., Ltd. received a patent certificate from the China National Intellectual Property Administration for a swine fever and porcine circovirus bivalent subunit vaccine, patent number ZL 2022 1 1403104.8, with the authorization announcement date of July 31, 2026.
Source:Jul 31, 2026, 07:43 UTC
Jinhe Biotech's board approved leasing an office space and parking spots in Hohhot from related party Wang Chunmiao for three years, with an annual rent of 930,000 yuan and a total amount of 2.79 million yuan.
Source:Jul 24, 2026, 04:03 UTC
Jinhe Biotechnology's application for a private placement of shares has been accepted for review.